Speaker Profile
MOHAMMAD ELNADI
Mohammad has a unique blend of both technical and business experience and qualifications. After graduating in pharmaceutical science, he has held posts in the fields of R&D and production of pharmaceutical dosage forms and as a toll manufacturing coordinator then, after completing postgraduate certificate in management from AUC, he has senior management roles in business development in pharmaceutical industry mainly in the area of planning, supply chain, process management & improvement and business excellence models and he leads teams for different QMS inspections as GMP & ISO 9001 inspections.
During his career in the supply chain, he took the responsibility of establishing & structuring the supply chain department within the company to cover production planning, inventory control, distribution inside & outside Egypt for pharmaceutical companies.
During his career life, he conducted a lot of training sessions as an internal training instructor for his team & as QMS consultant & instructor in REYADA PRO Consulting Co.

Mohammad Elnadi
September 12 2025
01 : 00 PM EST
60 Minutes
Drug Pricing Policies
The price of medicines is one of the factors that can limit the affordability of medicines to the population. So there are many drug pricing policies that could be implemented by the regulatory authorities based on the level of control they intend to implement on drug prices in the national market to assure that drugs are available in the market at fair prices. The national regulatory authority ma..

Mohammad Elnadi
October 08 2025
01 : 00 PM EST
60 Minutes
Developing Effective Regulatory Strategy In The Pharmaceutical Industry: Paving The Way From Concept To Commercialization
Regulatory strategy in the pharmaceutical industry refers to the plan put in place by a pharmaceutical company to ensure compliance with laws, regulations, and guidelines set forth by regulatory agencies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe or any other relevant drug regulatory authorities.Some key components of a successful reg..